awgldk
/
wikidata
/
Login
Register
TriplyDB
Wikidata
Browser
Table
SPARQL
Graphs
1
1
Services
1
1
Assets
0
0
Insights
Schema
BETA
Class frequency
Class hierarchy
Q26798462-794DE511-734D-48F4-A073-9DA26635EBB4
Q26798462-794DE511-734D-48F4-A073-9DA26635EBB4
BestRank
Statement
http://www.wikidata.org/entity/statement/Q26798462-794DE511-734D-48F4-A073-9DA26635EBB4
Mechanisms of hepatocellular carcinoma and challenges and opportunities for molecular targeted therapy
P2860
Q26798462-794DE511-734D-48F4-A073-9DA26635EBB4
BestRank
Statement
http://www.wikidata.org/entity/statement/Q26798462-794DE511-734D-48F4-A073-9DA26635EBB4
rank
NormalRank
type
BestRank
Statement
wasDerivedFrom
b384c10366f336be3a8b627f5e0e2a2e944c771a
P2860
Phase II, open-label study of brivanib as second-line therapy in patients with advanced hepatocellular carcinoma.